Menu

02/10/2026

Biological therapies: what we know today and where research is heading

Vitoria-Gasteiz will host the second edition of the MiKS International Congress on Biological Therapies in February 2027, bringing together researchers and healthcare professionals to share the latest advances and examine the role of biological therapies in clinical practice.

Biological therapies are part of a field of research that has evolved significantly in recent years. Platelet-rich plasma, cell-based therapies and other regenerative medicine strategies are currently being studied across a range of conditions and medical fields.

But when we talk about new therapies, one question is particularly important: what do we really know about them, and what remains to be investigated?

Answering this question requires research, collaboration and the careful assessment of evidence. This will be at the heart of the second edition of the MiKS International Congress on Biological Therapies, taking place from February 25–27, 2027, in Vitoria-Gasteiz.

What does this have to do with you?

WAdvances in medicine do not move directly from the laboratory to the clinic. Before a new approach can become part of clinical care, it needs to be studied, its results assessed and its potential benefits and limitations better understood.

For patients, this process matters because the development and use of new therapies should be supported by an increasingly robust body of scientific evidence.

A closer look at the evidence—and the questions that remain

Following a first edition that brought together nearly 400 professionals and specialists in Vitoria-Gasteiz, the congress will once again bring together researchers and healthcare professionals from different medical specialties and research fields.

The meeting also has the endorsement and support of leading scientific societies in the field of biological therapies and related disciplines, reinforcing its scientific and multidisciplinary character.

Across three days, the program will explore biological therapies in areas including musculoskeletal conditions and joint degeneration, sports medicine and pain management. It will also address regenerative medicine strategies, cell-based therapies and research into inflammation and biological aging.

Particular attention will be given to the results being obtained, factors that may influence treatment response and the questions that remain unanswered. The program will also examine the challenges of translating research findings into clinical practice, as well as the regulatory aspects involved in developing new therapies.

The congress will combine lectures, discussion panels, workshops and scientific communications. The participation of companies and specialized industry partners will also provide an opportunity to explore new technologies, products and developments in the field.

From research to clinical practice

Understanding a biological therapy means looking beyond whether it is being investigated. It requires asking what evidence exists, which patients have been studied, what results have been observed and what limitations remain.

The congress will therefore bring together research findings and clinical experience, with a focus on the challenges involved in translating emerging knowledge into patient care.

The aim is to foster a rigorous understanding of what a particular therapy may offer, when it may be appropriate and what its limitations are.

Supporting the professionals involved in patient recovery

The management of many musculoskeletal conditions involves different healthcare disciplines. Physicians, physiotherapists and other professionals may contribute at different stages of the recovery process.

As part of the congress activities, a workshop specifically aimed at physiotherapists will focus on biological therapies and their relationship with patient management and functional recovery.

The session will provide an opportunity to share knowledge and strengthen collaboration across the different stages of care.

Bringing some of the research closer to the public

Scientific knowledge does not have to remain within the professional community.

Alongside the congress, a public session is currently being developed to explore some of the main topics on the program in accessible language.

It will address questions that become increasingly relevant as we age: how aging affects our bodies, what we know about joint degeneration, the role of prevention and lifestyle, and what is currently being investigated to help maintain tissue health and function for longer.

The session will aim to explain what we currently know, distinguish evidence from ongoing research and make these topics easier to understand without unnecessary technical language.

The session is currently being prepared and more information will be shared soon.

An initiative from Vitoria-Gasteiz (Spain)

The MiKS International Congress on Biological Therapies is promoted by MiKS (Medical Innovation Knowledge Sharing), a medical and scientific community focused on knowledge exchange in biological therapies and regenerative medicine.

The congress is chaired by Dr. Mikel Sánchez, whose clinical and research career has focused on the study and development of biological therapies applied to the musculoskeletal system.

The second edition in Vitoria-Gasteiz will bring together researchers and healthcare professionals from different countries and specialties around a field of medicine that continues to evolve.

Because advancing medicine is not only about developing new therapies, but also about better understanding when they may be useful, for whom, and with what results.

MiKS International Congress on Biological Therapies

February 25–27, 2027
Europa Conference Centre · Vitoria-Gasteiz

More information about the program, speakers and registration is available at www.mikscongress.es.